advertisement
Pfeiffer N 9
Showing records 1 to 9 | Display all abstracts from Pfeiffer N125095 Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Sit AJ
Survey of Ophthalmology 2025; 70: 918-929
125806 Anti-TNFα and Anti-IL-1β Monoclonal Antibodies Preserve BV-2 Microglial Homeostasis Under Hypoxia by Mitigating Inflammatory Reactivity and ATF4/MAPK-Mediated Apoptosis
Zhang L
Antioxidants (Basel, Switzerland) 2025; 14:
125095 Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Aihara M
Survey of Ophthalmology 2025; 70: 918-929
125806 Anti-TNFα and Anti-IL-1β Monoclonal Antibodies Preserve BV-2 Microglial Homeostasis Under Hypoxia by Mitigating Inflammatory Reactivity and ATF4/MAPK-Mediated Apoptosis
Guan C; Wang S
Antioxidants (Basel, Switzerland) 2025; 14:
125095 Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Khawaja AP; Lin SC
Survey of Ophthalmology 2025; 70: 918-929
125806 Anti-TNFα and Anti-IL-1β Monoclonal Antibodies Preserve BV-2 Microglial Homeostasis Under Hypoxia by Mitigating Inflammatory Reactivity and ATF4/MAPK-Mediated Apoptosis
Pfeiffer N
Antioxidants (Basel, Switzerland) 2025; 14:
125095 Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Mansouri K
Survey of Ophthalmology 2025; 70: 918-929
125806 Anti-TNFα and Anti-IL-1β Monoclonal Antibodies Preserve BV-2 Microglial Homeostasis Under Hypoxia by Mitigating Inflammatory Reactivity and ATF4/MAPK-Mediated Apoptosis
Grus FH
Antioxidants (Basel, Switzerland) 2025; 14:
125095 Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors
Miki A; Park KH; Pfeiffer N; Weinreb RN
Survey of Ophthalmology 2025; 70: 918-929
